Science and Research

Dr Maryam Iftikhar

Cancer Nanomedicine Scientist

Junior Scientist, Institute of Nuclear Medicine and Oncology (INMOL), Lahore

Lahore, Pakistan

Biography

Dr Maryam Iftikhar is a scientist working in cancer nanomedicine, nanoparticle drug-delivery design and radiopharmaceutical science. Her research examines how nanocarrier morphology influences drug loading, delivery and interactions with biological systems, including preclinical models.

She earned her PhD in Biotechnology from the Pakistan Institute of Engineering and Applied Sciences (PIEAS) in July 2026 and undertook a six-month research fellowship at the University of Birmingham's School of Pharmacy through the HEC IRSIP programme.

At the Institute of Nuclear Medicine and Oncology (INMOL) in Lahore, she reports participating in radiopharmaceutical production and quality control for cancer imaging and therapy, including PSMA-targeted agents, under institutional procedures. She reports eight peer-reviewed journal articles and six book chapters. Alongside scientific research and mentoring, she founded SAN Foundation, a community initiative working in rural Sahiwal.

Her long-term objective is to support image-guided nanomedicine in Pakistan so that drug distribution through the body can be measured rather than assumed.

Areas of expertise

• Cancer Nanomedicine
• Nanoparticle Design for Drug Delivery
• Radiopharmaceuticals and Radiolabelled Nanomedicines
• Nanotoxicology and Immune Responses
• Research Mentoring and Scientific Communication

Selected experience

• PhD in Biotechnology, PIEAS (July 2026).
• HEC IRSIP research fellowship, School of Pharmacy, University of Birmingham.
• Junior Scientist at INMOL, Lahore since April 2026.
• Reports eight peer-reviewed journal articles and six book chapters.
• Founder, SAN Foundation, supporting communities in rural Sahiwal.

Engagement interests

Speaking, mentoring and other engagement availability to be confirmed.

Profiles reflect information provided for the directory. Engagement arrangements are subject to individual confirmation. Private contact details are not published. For enquiries, contact Balance 360.